ELOX — Eloxx Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Brief: Eloxx Pharmaceuticals Announces New Development Program For ELX-02 For The Treatment Of Alport Syndrome
Brief: Eloxx Pharmaceuticals Announces Therapeutic Development Award From Cystic Fibrosis Foundation
Eloxx Pharmaceuticals Inc expected to post a loss of 12 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baidu, Rockwell Medical, Star Bulk Carriers
Eloxx Pharma set for record low after lung disease treatment data disappoints
Brief: Eloxx Pharmaceuticals Reports Positive Topline Results From Phase 2 Clinical Trial Of Elx-02 In Class 1 Cystic Fibrosis Patients
Brief: Eloxx Pharmaceuticals Reports Q3 Loss Of 11 Cents Per Share
Eloxx Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
Eloxx Pharmaceuticals Inc expected to post a loss of 13 cents a share - Earnings Preview
Brief: Eloxx Pharmaceuticals Secures Debt Facility Of Up To $30 Million From Hercules Capital
Brief: Eloxx Says May Offer, Sell Shares Of Common Stock Of Up To $50 Mln
Brief: Eloxx Pharmaceuticals Announces Fast Track Designation For Elx-02 For Treatment Of Cystic Fibrosis Patients With Nonsense Mutations
U.S. STOCKS ON THE MOVE-Designer Brands, BioNTech, gold miners, Chinese tech stocks
Brief: Eloxx Pharmaceuticals Inc Files For Mixed Shelf Of Up To $200 Mln
Eloxx Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Eloxx Pharmaceuticals Reports Second Quarter 2021 Financial And Operating Results And Provides Business Update
Eloxx Pharmaceuticals Inc expected to post a loss of 14 cents a share - Earnings Preview
Eloxx Pharmaceuticals Inc expected to post a loss of 14 cents a share - Earnings Preview
Eloxx Pharmaceuticals Inc expected to post a loss of 14 cents a share - Earnings Preview